Pharmacokinetics of Insulin Detemir in Healthy Volunteers From Taiwan

A Single Centre, Open-labelled Trial to Investigate the Pharmacokinetics of Insulin Detemir in Healthy Taiwanese Subjects

This trial is conducted in Asia. The aim of this trial is to investigate pharmacokinetics of insulin detemir in healthy Taiwanese subjects.

Inclusion Criteria:

• Considered generally healthy upon completion of medical history and physical examination as judged by the investigator
• Body mass index (BMI) between 18 and 27 kg/m^2, inclusive
• Fasting plasma glucose maximum 6.1 mmol/l
• Non-smoker or smoking maximum 5 cigarettes per day or the equivalent

Exclusion Criteria:

• Participation in any other clinical trial involving other investigational products within the last 3 months
• Subject with a history of alcohol or drug dependence
• Subject with a first-degree relative with diabetes mellitus